SFM
BTMD icon

Spartan Fund Management’s Biote Corp BTMD Stock Holding History

Spartan Fund Management’s Portfolio BTMD Stock Details BTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-45,799
Closed -$566K – 455
2022
Q1 		$566K Buy
+45,799
New +$451K 0.09% 281

Other funds holding BTMD

CM
Cohanzick Management Pleasantville, New York $231K AUM 3.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TPMI
Tilden Park Management I New York $5.38M AUM 28.49% 1-Year Est. Return

Spartan Fund Management's BTMD Position: Q2 2022 in Review

Spartan Fund Management sold out of Biote Corp (BTMD) in Q2 2022, closing a stake of 45,799 shares — an estimated $566K sold.

Spartan Fund Management first reported a position in BTMD in Q1 2022 and held it in 1 quarter. The position peaked at $566K in Q1 2022. 12 funds tracked by Wall St. Rank hold BTMD as of Q2 2022.

  • Spartan Fund Management reported no remaining Biote Corp position as of Q2 2022 after selling out during the quarter.
  • Spartan Fund Management sold 45,799 Biote Corp shares in Q2 2022, an estimated $566K.
  • Spartan Fund Management first reported a position in Biote Corp in Q1 2022 and held it in 1 quarter.
  • Spartan Fund Management's Biote Corp position peaked at $566K in Q1 2022.
  • 12 funds tracked by Wall St. Rank held Biote Corp as of Q2 2022.

Based on Spartan Fund Management's 13F filing for Q2 2022, filed 26 Jul 2022.